A Randomized, Double-Blind, Placebo-Controlled, Multi-Centered Clinical Study to Evaluate the Efficacy and Safety of L. Extract for Improvement of Liver Function

Overview

Journal Clin Nutr Res

Date 2020 Nov 18

PMID 33204666

Citations 6

Authors

Byoungduck Han

Seon-Mee Kim

Ga Eun Nam

Seon-Hee Kim

Su-Jin Park

Young-Kyu Park

Hyun Wook Baik

Affiliations

Soon will be listed here.

Abstract

Non-alcoholic fatty liver disease (NAFLD) has the potential to develop into hepatic steatosis and progress to terminal liver diseases such as cirrhosis and hepatocellular carcinoma. This human clinical study was aimed to demonstrate that SPB-201 (powdered-water extract of ) can improve liver function in subjects with non-alcoholic liver dysfunction at mild to moderate levels. A decrease of 271% in aspartate aminotransferase (AST) level and a significant decrease of 334% in alanine aminotransferase (ALT) level was observed in the test group as compared to the control group at the 4 weeks follow-up. In addition, after 8 weeks, decreases of 199% in AST level and 216% in ALT level were reported in the test group as compared to the control group. These results confirmed that SPB-201 intake significantly enhanced liver function and health. Moreover, the Multidimensional Fatigue Scale score of the test group decreased but that of the control group increased, implicating that SPB-201 also eliminated overall fatigue. No significant adverse events were observed among all subjects during the study. Taken together, our clinical study confirmed the excellent efficacy and safety of SPB-201 in liver function improvement, showing the possibility of SPB-201 as a functional food to restore liver dysfunction and treat liver diseases.

Citing Articles

Evaluating Bioactive-Substance-Based Interventions for Adults with MASLD: Results from a Systematic Scoping Review.

Handu D, Stote K, Piemonte T Nutrients. 2025; 17(3).

PMID: 39940310 PMC: 11820841. DOI: 10.3390/nu17030453.

Differential Anti-Fibrotic and Remodeling Responses of Human Dermal Fibroblasts to sp., Artemisinin, and Its Derivatives.

Weathers P, Towler M, Kiani B, Dolivo D, Dominko T Molecules. 2024; 29(9).

PMID: 38731597 PMC: 11085156. DOI: 10.3390/molecules29092107.

Protective impacts of against hepatic toxicity induced by gentamicin.

Althobaiti S, Qahl S, Toufig H, Almalki D, Nasir O, Soliman M Toxicol Res (Camb). 2024; 13(1):tfad121.

PMID: 38162595 PMC: 10753289. DOI: 10.1093/toxres/tfad121.

Traditional uses, Phytochemistry, Pharmacology, and Toxicology of the Genus : A High-value Medicinal Plant.

Hussain M, Thakur R, Khazir J, Ahmed S, Khan M, Rahi P Curr Top Med Chem. 2023; 24(4):301-342.

PMID: 37711006 DOI: 10.2174/1568026623666230914104141.

Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis.

Wang L, Zhang P, Yan H Front Nutr. 2023; 10:1014010.

PMID: 36866059 PMC: 9971819. DOI: 10.3389/fnut.2023.1014010.

References

Dunn W, Xu R, Wingard D, Rogers C, Angulo P, Younossi Z . Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol. 2008; 103(9):2263-71. PMC: 2574666. DOI: 10.1111/j.1572-0241.2008.02034.x. View

Yang M, Guo M, Luo Y, Yun M, Yan J, Liu T . Effect of Artemisia annua extract on treating active rheumatoid arthritis: A randomized controlled trial. Chin J Integr Med. 2016; 23(7):496-503. DOI: 10.1007/s11655-016-2650-7. View

Asrani S, Devarbhavi H, Eaton J, Kamath P . Burden of liver diseases in the world. J Hepatol. 2018; 70(1):151-171. DOI: 10.1016/j.jhep.2018.09.014. View

Younossi Z, Anstee Q, Marietti M, Hardy T, Henry L, Eslam M . Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2017; 15(1):11-20. DOI: 10.1038/nrgastro.2017.109. View

Kim W, Choi W, Lee S, Kim W, Lee D, Sohn U . Anti-inflammatory, Antioxidant and Antimicrobial Effects of Artemisinin Extracts from Artemisia annua L. Korean J Physiol Pharmacol. 2015; 19(1):21-7. PMC: 4297758. DOI: 10.4196/kjpp.2015.19.1.21. View

Baek H, Shim H, Lim H, Shim M, Kim C, Park S . Anti-adipogenic effect of Artemisia annua in diet-induced-obesity mice model. J Vet Sci. 2015; 16(4):389-96. PMC: 4701730. DOI: 10.4142/jvs.2015.16.4.389. View

Cathebras P, Robbins J, Kirmayer L, Hayton B . Fatigue in primary care: prevalence, psychiatric comorbidity, illness behavior, and outcome. J Gen Intern Med. 1992; 7(3):276-86. DOI: 10.1007/BF02598083. View

Wong V, Wong G, Choi P, Chan A, Li M, Chan H . Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut. 2010; 59(7):969-74. DOI: 10.1136/gut.2009.205088. View

Adams L, Lymp J, Sauver J, Sanderson S, Lindor K, Feldstein A . The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005; 129(1):113-21. DOI: 10.1053/j.gastro.2005.04.014. View

10.

Park C, Choi E, Yang H, Ho S, Park S, Park K . Efficacy of L. extract for recovery of acute liver failure. Food Sci Nutr. 2020; 8(7):3738-3749. PMC: 7382175. DOI: 10.1002/fsn3.1662. View

11.

Park S, Plank L, Suk K, Park Y, Lee J, Choi J . Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017. Clin Mol Hepatol. 2019; 26(2):209-215. PMC: 7160351. DOI: 10.3350/cmh.2019.0065. View

12.

Iqbal S, Younas U, Chan K, Zia-Ul-Haq M, Ismail M . Chemical composition of Artemisia annua L. leaves and antioxidant potential of extracts as a function of extraction solvents. Molecules. 2012; 17(5):6020-32. PMC: 6268588. DOI: 10.3390/molecules17056020. View

13.

Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar C . The anti-malarial artesunate is also active against cancer. Int J Oncol. 2001; 18(4):767-73. DOI: 10.3892/ijo.18.4.767. View

14.

Kim M, Seo J, Liu K, Kim J . Protective effect of Artemisia annua L. extract against galactose-induced oxidative stress in mice. PLoS One. 2014; 9(7):e101486. PMC: 4079707. DOI: 10.1371/journal.pone.0101486. View

15.

Chang S, Koh S, Kang M, Hyun S, Cha B, Park J . [Correlates of self-rated fatigue in Korean employees]. J Prev Med Public Health. 2005; 38(1):71-81. View

16.

Schreiber A, Harter G, Schubert A, Bunjes D, Mertens T, Michel D . Antiviral treatment of cytomegalovirus infection and resistant strains. Expert Opin Pharmacother. 2009; 10(2):191-209. DOI: 10.1517/14656560802678138. View

17.

Ho W, Peh H, Chan T, Wong W . Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol Ther. 2013; 142(1):126-39. DOI: 10.1016/j.pharmthera.2013.12.001. View

18.

Hunt S, Stebbings S, McNamara D . An open-label six-month extension study to investigate the safety and efficacy of an extract of Artemisia annua for managing pain, stiffness and functional limitation associated with osteoarthritis of the hip and knee. N Z Med J. 2016; 129(1444):97-102. View

19.

Schwartz J, Jandorf L, Krupp L . The measurement of fatigue: a new instrument. J Psychosom Res. 1993; 37(7):753-62. DOI: 10.1016/0022-3999(93)90104-n. View

20.

Kim K, Ko K, Heo R, Yi C, Shin H, Kim J . Artemisia annua Leaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice. J Med Food. 2016; 19(3):290-9. PMC: 4799707. DOI: 10.1089/jmf.2015.3527. View